GALLEON PHARMACEUTICALS, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for GALLEON PHARMACEUTICALS, INC..The latest application filed is for "novel breathing control modulating compounds, and methods of making and using same".

Company Profile

0.6.14

GALLEON PHARMACEUTICALS, INC. - Doylestown PA US
GALLEON PHARMACEUTICALS, INC. - Horsham PA US
GALLEON PHARMACEUTICALS, INC. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same App 20180141953 - DAX; Scott L. ; et al.	2018-05-24
Breathing control modulating compounds, and methods of using same Grant 9,643,971 - Dax , et al. May 9, 2	2017-05-09
Novel Compounds As Respiratory Stimulants For Treatment Of Breathing Control Disorders Or Diseases App 20160256463 - DAX; SCOTT L. ; et al.	2016-09-08
Compounds as respiratory stimulants for treatment of breathing control disorders or diseases Grant 9,351,972 - Dax , et al. May 31, 2	2016-05-31
Novel Breathing Control Modulating Compounds, And Methods Of Using Same App 20160046635 - DAX; SCOTT ; et al.	2016-02-18
Novel Compounds And Compositions For Treatment Of Breathing Control Disorders Or Diseases App 20150374706 - MANNION; JAMES C. ; et al.	2015-12-31
Compounds and compositions for treatment of breathing control disorders or diseases Grant 9,162,992 - Mannion , et al. October 20, 2	2015-10-20
Novel Orally Bioavailable Breathing Control Modulating Compounds, And Methods Of Using Same App 20150291597 - Mannion; James C. ; et al.	2015-10-15
Analgesic compounds, compositions, and uses thereof Grant 9,102,636 - Mannion , et al. August 11, 2	2015-08-11
Novel Compounds And Compositions For Treatment Of Breathing Control Disorders Or Diseases App 20140371224 - MANNION; JAMES C. ; et al.	2014-12-18
Novel Methods for Preparation of (+)-1-ethyl-4-[2-(4-morpholinyl)ethyl)-3,3-diphenyl-2-pyrrolidinone App 20130109689 - Dax; Scott L. ; et al.	2013-05-02
Novel Methods for Preparation of (+)-1-ethyl-4-[2-(4-morpholinyl)ethyl)-3,3-diphenyl-2-pyrrolidinone and Salts Thereof App 20130109854 - Dax; Scott L. ; et al.	2013-05-02
Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases App 20120295911 - Mannion; James C. ; et al.	2012-11-22
Novel Compositions and Therapeutic Methods Using Same App 20120270848 - Mannion; James C. ; et al.	2012-10-25
Analgesic Compounds, Compositions and Uses Thereof App 20120202860 - Mannion; James ; et al.	2012-08-09
Novel Compounds as Respiratory Stimulants for Treatment of Breathing Control Disorders or Diseases App 20120142647 - Dax; Scott L. ; et al.	2012-06-07
Analgesic Compounds, Compositions, and Uses Thereof App 20110224269 - Mannion; James C. ; et al.	2011-09-15
S-Nitrosothiol Compounds and Related Derivatives App 20100105685 - Mannion; James C.	2010-04-29

Company Registrations

SEC

0001387973

GALLEON PHARMACEUTICALS INC of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.